Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10567 | BMS-214662 | Raf | MAPK |
BMS-214662是一种有效的、有选择性的 farnesyl transferase 抑制剂,可诱导原始CD34+慢性髓性白血病(CML)干细胞/祖细胞的线粒体凋亡,具有选择性靶向CML 干细胞/祖细胞的能力,具有抗肿瘤活性。 | |||
T68227 |
BMS-214662 HCl
|
||
BMS-214662 is a Farnesyltransferase inhibitor , is also a nonsedating benzodiazepine derivative with potential antineoplastic activity. BMS-214662 inhibits the enzyme farnesyltransferase and the post-translational farnesylation of number of proteins involved in signal transduction, which may result in the inhibition of Ras function and apoptosis in susceptible tumor cells. This agent may reverse the malignant phenotype of H-Ras-transformed cells and has been shown to be active against tumor cell... |